Hem › Icke-småcellig lungcancer › New Jersey › Clifton
Kliniska studier för Icke-småcellig lungcancer i Clifton, NJ
24 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Clifton (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekryterarFas 1
- Hackensack University Medical Center, Hackensack · 7 mi bort
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #105, Hackensack · 7 mi bort
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RekryterarFas 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152), Hackensack · 7 mi bort
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekryterarFas 3
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi bort
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekryterarFas 2
- Hackensack University Medical Center, Hackensack · 7 mi bort
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekryterarFas 1/2
- Hackensack University Medical Center, Hackensack · 7 mi bort
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi bort
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekryterarFas 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi bort
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RekryterarFas 1
- Hackensack University Medical Center, Hackensack · 7 mi bort
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekryterarFas 1/2
- Hackensack University Medical Center, Hackensack · 7 mi bort
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekryterarFas 1/2
- Hackensack University Medical Center, Hackensack · 7 mi bort
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- John Theurer Cancer Center, Hackensack · 7 mi bort
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
RekryterarFas 2
- Hackensack Meridian Health, Hackensack · 7 mi bort
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
RekryterarFas 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0035), Hackensack · 7 mi bort
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RekryterarFas 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi bort
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekryterarFas 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi bort
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekryterarFas 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi bort
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- John Theurer Cancer Center, Hackensack · 7 mi bort
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekryterarFas 1
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack · 7 mi bort
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
RekryterarFas 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi bort
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekryterarFas 1
- Hackensack University Medical Center, Hackensack · 7 mi bort
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
RekryterarFas 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi bort
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- John Theurer Cancer Center At Hackensack UMC, Hackensack · 7 mi bort
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekryterarFas 1
- Hackensack University Medical Center, Hackensack · 7 mi bort
RAPA-201 Therapy of Solid Tumors
RekryterarFas 1/2
- Hackensack University Medical Center, Hackensack · 7 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Clifton
- Cancer (alla typer)15 studier
- Multipelt myelom14 studier
- Metastaserande cancer12 studier
- Akut myeloid leukemi12 studier
- Bröstcancer12 studier
- Prostatacancer12 studier
- Äggstockscancer11 studier
- Lungcancer10 studier
- Kolorektal cancer8 studier
- Plattenepitelcancer i huvud och hals8 studier
- Endometriecancer8 studier
- Hjärtsvikt8 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.